Cancer

We have a clear aspiration – to transform the lives of people with cancer by delivering meaningful advances, with the ultimate goal of curing a range of cancers. Our generational commitment to driving scientific innovation is reflected by our robust pipeline of cancer cell-directed and immuno-oncology investigational therapies, as well as the smart combination of these approaches.

We are taking a diligent and broad approach, creating a collaborative research network to tap into a diversity of minds, which is vital in addressing some of the most challenging, but potentially most impactful, areas of cancer research. Simply put, for Boehringer Ingelheim, cancer care is personal, today and for generations.

Collaborations

When it comes to winning the fight against cancer, we’re brighter together. Collaboration is fundamental to unravelling the complexities of cancer and developing breakthrough treatments with demonstrable value. As an oncology partner of choice, we are involved in long-term collaborations with many of the world’s leading academic, industry and advocacy organizations. Our approach is grounded in mutual trust, shared goals and a passion for leading science

[Read more](/content/partnering/human-health-partnering/partnering-interests/oncology "Read more"/index.html)

Oncology and Cancer Immunology Partnering Interests

Working together with our collaboration partners, Boehringer Ingelheim is leading the way in the search for novel therapeutic concepts, biomarkers, drug candidates and treatment modalities in oncology and cancer immunology.

[Read more](/content/partnering/human-health-partnering/partnering-interests/oncology "Read more"/index.html)

Cancer is One of Humanity’s Greatest Challenges

Oncology has one of the highest unmet needs in the entire healthcare industry. Despite treatment advances, people are still dying from cancer earlier than they should.

[Read more](/content/ca/human-health/cancer/cancer-one-humanitys-greatest-challenges "Read more"/index.html)

References